Table 2 Pathological characteristics in two group of patients. Data are presented as proportion of individuals within each category
CNV = 2 | CNV > 2 | P value | |
|---|---|---|---|
Age at diagnosis (years) | 60.4 ± 14.5 | 61.4 ± 13.6 | 0.74 |
Menopausal status | 0.70 | ||
Premenopausal | 20.9% | 10% | |
Perimenopausal | 3.7% | 0.0% | |
Menopausal | 75.4% | 90% | |
Estrogen receptor | 0.84 | ||
Positive | 67.8% | 80% | |
Negative | 32.2% | 20% | |
Progesterone receptor | 0.35 | ||
Positive | 53% | 30% | |
Negative | 47% | 70% | |
HER-2 status | 0.99 | ||
Positive | 70.1% | 70% | |
Negative | 29.9% | 30% | |
Palpable tumour | 0.07 | ||
Yes | 93.6% | 70% | |
No | 6.4% | 30% | |
Lymph node status | 0.04* | ||
Negative | 58.2% | 80% | |
Positive | 41.8% | 20% | |
Tumour type | 0.93 | ||
Invasive ductal carcinoma (IDC) | 72.9% | 80% | |
Ductal carcinoma in situ (DCIS) | 5.7% | 0.0% | |
Lobular | 15.7% | 20% | |
D & L | 1% | 0.0% | |
Other | 2.9% | 0.0% | |
Histological grade | 0.36 | ||
I | 11.1% | 0% | |
II | 51.9% | 70% | |
III | 37% | 30% | |
Location | 0.04* | ||
Unilateral | 95.5% | 80% | |
Bilateral | 2.5% | 20% | |
Familial history | 0.001* | ||
Yes | 45% | 100% | |
No | 55% | 0% | |
Size (cm) | 0.64 | ||
< 2 | 59% | 60% | |
> 2 | 41% | 40% | |
Vascular invasion | 0.21 | ||
Yes | 81% | 0% | |
No | 19% | 100% | |